140 related articles for article (PubMed ID: 18341614)
1. Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.
Sellner J; Greeve I; Findling O; Grandgirard D; Leib SL; Mattle HP
Clin Exp Immunol; 2008 May; 152(2):280-4. PubMed ID: 18341614
[TBL] [Abstract][Full Text] [Related]
2. Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
Paul F; Waiczies S; Wuerfel J; Bellmann-Strobl J; Dörr J; Waiczies H; Haertle M; Wernecke KD; Volk HD; Aktas O; Zipp F
PLoS One; 2008 Apr; 3(4):e1928. PubMed ID: 18398457
[TBL] [Abstract][Full Text] [Related]
3. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
Birnbaum G; Cree B; Altafullah I; Zinser M; Reder AT
Neurology; 2008 Oct; 71(18):1390-5. PubMed ID: 18525027
[TBL] [Abstract][Full Text] [Related]
4. SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology.
Kamm CP; Mattle HP;
Trials; 2009 Dec; 10():115. PubMed ID: 20003436
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis.
Sellner J; Greeve I; Mattle HP
Mult Scler; 2008 Aug; 14(7):981-4. PubMed ID: 18573823
[TBL] [Abstract][Full Text] [Related]
6. Soluble forms of CD95 and CD95 ligand after living related liver transplantation.
Seino K; Kayagaki N; Yamaguchi N; Takada Y; Uyama S; Kiuchi T; Tanaka K; Yagita H; Okumura K; Fukao K
Transplantation; 1999 Feb; 67(4):634-6. PubMed ID: 10071041
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial.
Kamm CP; El-Koussy M; Humpert S; Findling O; Burren Y; Schwegler G; Donati F; Müller M; Müller F; Slotboom J; Kappos L; Naegelin Y; Mattle HP;
PLoS One; 2014; 9(1):e86663. PubMed ID: 24497963
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial.
Kamm CP; El-Koussy M; Humpert S; Findling O; von Bredow F; Burren Y; Schwegler G; Schött D; Donati F; Müller M; Goebels N; Müller F; Slotboom J; Tettenborn B; Kappos L; Naegelin Y; Mattle HP
J Neurol; 2012 Nov; 259(11):2401-13. PubMed ID: 22569835
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
Lanzillo R; Orefice G; Quarantelli M; Rinaldi C; Prinster A; Ventrella G; Spitaleri D; Lus G; Vacca G; Carotenuto B; Salvatore E; Brunetti A; Tedeschi G; Brescia Morra V
Mult Scler; 2010 Apr; 16(4):450-4. PubMed ID: 20150398
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy.
Ehrlich S; Haas J; Zipp F; Infante-Duarte C
J Neurol Sci; 2007 Jan; 252(1):83-7. PubMed ID: 17169375
[TBL] [Abstract][Full Text] [Related]
11. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
Rep MH; Schrijver HM; van Lopik T; Hintzen RQ; Roos MT; Adèr HJ; Polman CH; van Lier RA
J Neuroimmunol; 1999 Apr; 96(1):92-100. PubMed ID: 10227428
[TBL] [Abstract][Full Text] [Related]
12. No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).
Lanzillo R; Quarantelli M; Pozzilli C; Trojano M; Amato MP; Marrosu MG; Francia A; Florio C; Orefice G; Tedeschi G; Bellantonio P; Annunziata P; Grimaldi LM; Comerci M; Brunetti A; Bonavita V; Alfano B; Marini S; Brescia Morra V;
Mult Scler; 2016 Aug; 22(9):1163-73. PubMed ID: 26466947
[TBL] [Abstract][Full Text] [Related]
13. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
Salvatore E; Morra VB; Orefice G
Neurology; 2009 Sep; 73(13):1078; author reply 1078-9. PubMed ID: 19786703
[No Abstract] [Full Text] [Related]
14. Statins for multiple sclerosis.
Wang J; Xiao Y; Luo M; Zhang X; Luo H
Cochrane Database Syst Rev; 2010 Dec; (12):CD008386. PubMed ID: 21154395
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis.
Sellner J; Greeve I; Leib SL; Mattle HP
Arch Neurol; 2008 May; 65(5):672-4. PubMed ID: 18474748
[No Abstract] [Full Text] [Related]
16. Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer.
Aguilar-Lemarroy A; Romero-Ramos JE; Olimon-Andalon V; Hernandez-Flores G; Lerma-Diaz JM; Ortiz-Lazareno PC; Morgan-Villela G; Del Toro-Arreola S; Bravo-Cuellar A; Jave-Suarez LF
BMC Cancer; 2008 Apr; 8():99. PubMed ID: 18405371
[TBL] [Abstract][Full Text] [Related]
17. Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neuhaus O; Strasser-Fuchs S; Fazekas F; Kieseier BC; Niederwieser G; Hartung HP; Archelos JJ
Neurology; 2002 Oct; 59(7):990-7. PubMed ID: 12370451
[TBL] [Abstract][Full Text] [Related]
18. Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients.
Marín LA; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Ramírez P; García-Alonso AM; Parrilla P; Alvarez-López MR; Muro M
Transpl Immunol; 2012 Mar; 26(2-3):94-100. PubMed ID: 22182632
[TBL] [Abstract][Full Text] [Related]
19. CD95-mediated apoptosis and DNA fragmentation in MS.
Heesen C; Georghiu S; Gbadamosi J; Schoser BG
Acta Neurol Scand; 2000 Nov; 102(5):333-6. PubMed ID: 11083512
[TBL] [Abstract][Full Text] [Related]
20. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
